Non-alcoholic fatty liver disease (NAFLD) is a major public health issue worldwide. It is the
most common liver disease in Western countries, andits global prevalence is estimated to be …

Liver fibrosis is a wound-healing response due to persistent liver damage and it may
progress to cirrhosis and even liver cancer if no intervention is given. In the current …

Background Nonalcoholic fatty liver disease (NAFLD) is a chronic disease with an
increasing incidence, which can further develop into liver fibrosis and hepatocellular …

Metabolic dysfunction-associated steatotic liver disease (MASLD) is a growing healthcare
problem with limited therapeutic options. Progress in this field depends on the availability of …

Abstract Ethnopharmacological relevance Ginseng (Panax ginseng CA Meyer) is a precious
traditional Chinese medicine with multiple pharmacological effects. Ginsenoside Rg1 is a …

Hepatic fibrosis (HF), a precursor to cirrhosis and hepatocellular carcinoma, is caused by
abnormal proliferation of connective tissue and excessive accumulation of extracellular …

Metabolic-associated fatty liver disease (MAFLD) is the most common chronic liver disease
observed in clinical practice worldwide. This disorder has been independently associated …

Objective Hepatic overexpression of the thrombospondin 2 gene (THBS2) and elevated
levels of circulating thrombospondin 2 (TSP2) have been observed in patients with chronic …

Non-alcoholic fatty liver disease (NAFLD), the leading cause of chronic liver disease in
Western countries, has been identified as a possible risk factor for COVID-19 severity …

In this editorial we expand the discussion on the article by Zhang et al published in the
recent issue of the World Journal of Hepatology. We focus on the diagnostic and therapeutic …